Literature DB >> 11815677

An aged mouse model for RSV infection and diminished CD8(+) CTL responses.

Yongxin Zhang1, Ying Wang, Xyanthine Gilmore, Keyi Xu, Philip R Wyde, Innocent N Mbawuike.   

Abstract

Recent studies indicate that respiratory syncytial virus (RSV), like influenza, causes significant morbidity and mortality among elderly persons. There are currently no animal models to study the effects of aging on RSV disease and immunity. This manuscript provides an initial description of such a model. Aged and young BALB/c mice (22-24 and 2-4 months, respectively) were infected with 10(4) TCID(50) of RSV A2. RSV was detected by culture in lung and nose wash specimens obtained 4-6 days following infection at a slightly higher titer in old mice in comparison with young mice. RT-PCR assay detected RSV in the lungs and nose washes of all mice on 4, 8, and 21 days postinoculation, with only a slightly less frequency in young mice. Splenic lymphocytes from old mice exhibited significantly lower RSV-specific MHC class I-restricted CD8(+) CTL responses (P < 0.01-0001), and reduced IFN-production (P < 0.03) than young mice. Conversely, IL-4 production was somewhat elevated in old mice. These results demonstrate diminished RSV virus-specific CD8(+)CTL responses and IFN-gamma production in old mice in comparison with young. It is speculated that the deficient RSV-specific CTL responses may account for the increased morbidity and mortality from RSV infections in elderly persons. Although detailed histopathological, virological, and immunological analyses are incomplete at present, the old BALB/c RSV infection model described provides an opportunity to evaluate the role of CD8(+)CTL and cytokines in RSV disease in aging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815677     DOI: 10.1177/153537020222700208

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  21 in total

1.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

2.  Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus.

Authors:  Tracey Baas; Anjeanette Roberts; Thomas H Teal; Leatrice Vogel; Jun Chen; Terrence M Tumpey; Michael G Katze; Kanta Subbarao
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

Review 3.  Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Authors:  Judy Chen; William J Kelley; Daniel R Goldstein
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

4.  Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.

Authors:  Marie-Eve Hamelin; Kevin Yim; Katie H Kuhn; Rose P Cragin; Marina Boukhvalova; Jorge C G Blanco; Gregory A Prince; Guy Boivin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Vaccine development for respiratory syncytial virus.

Authors:  Barney S Graham
Journal:  Curr Opin Virol       Date:  2017-05-16       Impact factor: 7.090

6.  Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans.

Authors:  Anjeanette Roberts; Christopher Paddock; Leatrice Vogel; Emily Butler; Sherif Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.

Authors:  Sujin Lee; Robert S Mittler; Martin L Moore
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

8.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

9.  Vaccines against respiratory syncytial virus: The time has finally come.

Authors:  Barney S Graham
Journal:  Vaccine       Date:  2016-05-13       Impact factor: 3.641

Review 10.  Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Authors:  Matthew R Olson; Steven M Varga
Journal:  Expert Rev Vaccines       Date:  2008-10       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.